Published on 30 April 2013
Pharmacokinetics of antimicrobials in obese children
Author(s): et al., Mario R Sampson, PharmD
antimicrobial agents, obesity, paediatric, pharmacokinetics
DOI: 10.5639/gabij.2013.0202.025
23.463 views
Published on 30 April 2013
Author(s): et al., Mario R Sampson, PharmD
antimicrobial agents, obesity, paediatric, pharmacokinetics
DOI: 10.5639/gabij.2013.0202.025
23.463 views
Published on 30 April 2013
Author(s): Barbara Milani, Sara Gaspani
drug access, generics, liposomal amphotericin B, liposomal doxorubicin, visceral leishmaniasis
DOI: 10.5639/gabij.2013.0202.022
42.633 views
Published on 24 April 2013
Author(s): Professor Teun van Gelder, MD, PhD
ciclosporin, generics substitution, immunosuppression, mycophenolate, tacrolimus, transplantation
DOI: 10.5639/gabij.2013.0203.031
23.609 views
Published on 24 April 2013
Author(s): Angela Vogt-Eisele, PhD, Professor Marietta Kaszkin-Bettag, PhD, Tilo Netzer, PhD, Wolfram Hildebrandt, MSc, MA, Tobias Blank, PhD
biosimilar regulation, biosimilar safety (EU USA), biosimilar toxicity, immunogenicity, pharmacovigilance, traceability
DOI: 10.5639/gabij.2013.0203.039
35.244 views
Published on 24 April 2013
Author(s): GaBI Journal Editor
DOI: 10.5639/gabij.2013.0204.055
17.241 views
Published on 24 April 2013
Author(s): Claudia Habl, Sabine Vogler, PhD, Nina Zimmermann, MA
health expenditures, hospital sector, medicine prices, pharmaceutical expenditure, policy, volume
DOI: 10.5639/gabij.2013.0204.051
63.362 views
Published on 06 August 2019
Author(s): Andrea Laslop, MD, Jian Wang, MD, PhD, Robin Thorpe, PhD, FRCPath
biosimilars, costs, MENA (Middle East and North Africa), pharmacovigilance, regulators, switching
DOI: 10.5639/gabij.2019.0802.009
11.217 views
Published on 24 April 2013
Author(s): et al., Shih-Ting Chiu, MSc
extra-reference design, generalized pivotal quantity, individual bioequivalence, replicated crossover design
DOI: 10.5639/gabij.2013.0203.037
26.663 views
Published on 22 April 2013
Author(s): Alessandro Curto, MSSc, Katelijne Van de Vooren, MSc, Professor Livio Garattini, Roberta Lo Muto, MSc, Silvy Duranti, MBA
biosimilars, competition, Italy, regions, tender
DOI: 10.5639/gabij.2013.0203.036
19.933 views
Published on 19 April 2013
Author(s): GaBI Journal Editor
febrile neutropenia, G-CSF, leukaemia, lymphoma, myelosuppression, risk
DOI: 10.5639/gabij.2013.0201.016
8.564 views
Published on 19 April 2013
Author(s): Professor Philip D Walson, MD
DOI: 10.5639/gabij.2013.0201.015
6.443 views
Published on 18 April 2013
Author(s): Saleh Karamah AL-Tamimi, BPharm, MPharm (ClinPharm), Mohamed Azmi Ahmad Hassali, PhD, Alian A Alrasheedy, BPharm(Hons), MPharm(Clin), BCPS
challenges, consumers, generic medicines, healthcare professionals, Yemen
DOI: 10.5639/gabij.2013.0202.017
13.739 views